Factors affecting hematopoietic progenitor cell mobilization: An analysis of 307 patients


Autoria(s): MENDRONE JR., Alfredo; ARRAIS, Cyntia Araujo; SABOYA, Rosaura; CHAMONE, Dalton de Alencar Fischer; DULLEY, Frederico Luiz
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2008

Resumo

We reviewed the data of 307 patients treated with autologous bone marrow transplantation with the aim to identify factors associated with poor hematopoietic stern cell (HSC) mobilization after administration of cyclophosphamide and granulocyte-colony stimulating factor. Success in mobilization was defined when >= 2.0 x 10(6) CD34+ cells/kg weight could be collected with <= 3 leukapheresis procedures. Success was observed in 260 patients (84.7%) and nonsuccess in 47 patients (15.3%). According to the stepwise regression model: diagnosis, chemotherapy load, treatment with mitoxantrone and platelet count before mobilization were found to be independent predictive factors for HSC mobilization. These results could help in the previous recognition of patients at risk for non response to mobilization and allow to plan an alternative protocol for this group of patients. (C) 2008 Elsevier Ltd. All rights reserved.

Identificador

TRANSFUSION AND APHERESIS SCIENCE, v.39, n.3, p.187-192, 2008

1473-0502

http://producao.usp.br/handle/BDPI/21623

10.1016/j.transci.2008.09.012

http://dx.doi.org/10.1016/j.transci.2008.09.012

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

Relação

Transfusion and Apheresis Science

Direitos

restrictedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #Hematopoietic stem cell mobilization #Autologous bone marrow transplantation #Granulocyte-colony stimulating factor (G-CSF) #COLONY-STIMULATING FACTOR #BLOOD STEM-CELLS #HIGH-DOSE CYCLOPHOSPHAMIDE #PLUS G-CSF #PERIPHERAL-BLOOD #MULTIPLE-MYELOMA #BONE-MARROW #CHEMOTHERAPY #TRANSPLANTATION #LYMPHOMA #Hematology
Tipo

article

original article

publishedVersion